It has been a mixed year for WORK Medical Technology Group LTD insiders: $1.4 million bought by one person and $1 million sold by one, so more buying than selling overall.
The largest purchase came from HRT FINANCIAL LP (10% Owner), about $384,000.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 880,456 | $0.05 | $44K | SEC |
| Jun 17, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 268,927 | $0.10 | $27K | SEC |
| Jun 17, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 2,904,567 | $0.06 | $174K | SEC |
| Jun 16, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 48,108 | $0.08 | $4K | SEC |
| Jun 12, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 1,765,384 | $0.10 | $177K | SEC |
| Jun 12, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 2,029,327 | $0.09 | $183K | SEC |
| Jun 10, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 3,463,022 | $0.11 | $381K | SEC |
| Jun 9, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 2,261,118 | $0.11 | $249K | SEC |
| Jun 8, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 1,370,008 | $0.11 | $151K | SEC |
| Jun 8, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 54,529 | $0.09 | $5K | SEC |
| Jun 3, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 2,746,332 | $0.14 | $384K | SEC |
| Jun 3, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 1,757,955 | $0.11 | $193K | SEC |
| Jun 1, 2026 | HRT FINANCIAL LP | 10% Owner | Sell | 2,619,607 | $0.10 | $262K | SEC |
| Jun 1, 2026 | HRT FINANCIAL LP | 10% Owner | Buy | 1,535,850 | $0.09 | $138K | SEC |
In the last 12 months WORK Medical Technology Group LTD insiders made open-market purchases worth about $1.4 million and sales worth about $1 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in WOK was filed on 2026-06-23.
No congressional trades in WOK were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).